Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on developing curative therapeutics leveraging CRISPR-based technologies, today announced that the company is scheduled to present virtually at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 2:15 p.m. ET.
A live audio webcast of Intellia's presentation can be accessed under the Events and Presentations page of the Investors & Media section on the company's website. A replay of the audio webcast will be available on Intellia's website for at least two weeks following the presentation.